Jean Bennett was a founder of GenSight Biologics and Opus Genetics and was a scientific (non-equity holding) founder of Spark Therapeutics. She and her husband waived any potential financial gain from ...
WASHINGTON (AP) — The first gene therapy for a deadly form of muscular dystrophy received preliminary U.S. approval on Thursday despite concerns from some government scientists about the treatment’s ...
Uncommon forms of therapy helping anxiety, depression, other mental health issues. Uncommon forms of therapy helping anxiety, depression, other mental health issues. Uncommon forms of therapy helping ...
Since so many competing forms of therapy are currently available, patients seeking treatment may not always know the differences in approach among them, or even how each school of thought understands ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — The first gene therapy for ...
WASHINGTON (AP) — The first gene therapy for a deadly form of muscular dystrophy received preliminary U.S. approval on Thursday despite concerns from some government scientists about the treatment's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results